SCHEMBL3755397

SCHEMBL3755397

CCOC(=O)c1c(N2CCOCC2)sc2c1CC(C)(C)NC2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.47
PIK3CD O00329 1/20 0.47
PIK3CB P42338 1/20 0.47
PIK3CG P48736 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 10/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
MAP2K2 P36507 2/20 0.38
MAP2K1 Q02750 2/20 0.38
GAA P10253 2/20 0.38
ALOX15 P16050 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764678 0.88 MAP2K2 (0.49) PIK3CAL3MBTL1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3764745 0.84 PIK3CD (0.52) PIK3CAPIK3CDPIK3CBPIK3CGL3MBTL1
SCHEMBL3759473 0.84 PIK3CD (0.52) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3758593 0.82 PIK3CD (0.43) PIK3CAPIK3CDPIK3CBPIK3CGL3MBTL1
SCHEMBL3760020 0.79 ALDH1A1 (0.51) L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPSR1
SCHEMBL3761551 0.78 MAP2K2 (0.44) L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPSR1
SCHEMBL3763214 0.77 PIK3CD (0.45) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3763208 0.77 PIK3CD (0.45) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3761681 0.77 PIK3CD (0.54) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL360530 0.76 ALDH1A1 (0.67) PIK3CAPIK3CDPIK3CBPIK3CGL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885PIK3CD 9/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.